Nothing Special   »   [go: up one dir, main page]

LU83081A1 - Compositions antitumeurs - Google Patents

Compositions antitumeurs Download PDF

Info

Publication number
LU83081A1
LU83081A1 LU83081A LU83081A LU83081A1 LU 83081 A1 LU83081 A1 LU 83081A1 LU 83081 A LU83081 A LU 83081A LU 83081 A LU83081 A LU 83081A LU 83081 A1 LU83081 A1 LU 83081A1
Authority
LU
Luxembourg
Prior art keywords
anisidide
methanesulfone
acridinylamino
organic acid
gluconolactone
Prior art date
Application number
LU83081A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26812557&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU83081(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83081A1 publication Critical patent/LU83081A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU83081A 1980-01-24 1981-01-23 Compositions antitumeurs LU83081A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11480980A 1980-01-24 1980-01-24
US11480980 1980-01-24
US06/194,350 US4322424A (en) 1980-01-24 1980-10-17 Crystalline glucoconate salt of m-AMSA and compositions containing same
US19435080 1980-10-17

Publications (1)

Publication Number Publication Date
LU83081A1 true LU83081A1 (fr) 1981-09-10

Family

ID=26812557

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83081A LU83081A1 (fr) 1980-01-24 1981-01-23 Compositions antitumeurs

Country Status (17)

Country Link
US (1) US4322424A (el)
AT (1) AT380474B (el)
AU (1) AU543758B2 (el)
CA (1) CA1252103A (el)
CH (1) CH648023A5 (el)
DE (1) DE3102026A1 (el)
DK (1) DK29781A (el)
FI (1) FI79840C (el)
FR (1) FR2474493B1 (el)
GB (1) GB2068729B (el)
GR (1) GR82326B (el)
IE (1) IE50884B1 (el)
IT (1) IT1170638B (el)
LU (1) LU83081A1 (el)
NL (1) NL8100292A (el)
SE (1) SE453497B (el)
YU (1) YU42552B (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186383B (en) * 1981-02-27 1985-07-29 Biogal Gyogyszergyar Process for producing new citostatic amni-acridie-alpha, beta-bracket-d-bracket closed, or aracket-l-bracket closed-n-glycoside derivatives and salts
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1674923A (en) * 1924-04-12 1928-06-26 Schnorf Carl Process for the production of carbohydrate-acridine compounds and solutions thereof
US3839344A (en) * 1973-03-28 1974-10-01 Schering Corp N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid
US4258191A (en) * 1979-03-29 1981-03-24 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Multi-step process for the production of methanesulfon-m-anisidide, 4'-(9-acridinylamino)-
AU534608B2 (en) * 1979-09-14 1984-02-09 Warner-Lambert Corporation Compounds having antitumour properties
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Also Published As

Publication number Publication date
NL8100292A (nl) 1981-08-17
DK29781A (da) 1981-07-25
GR82326B (el) 1984-12-13
YU14581A (en) 1983-06-30
CA1252103A (en) 1989-04-04
IE810119L (en) 1981-07-24
IT8147604A1 (it) 1982-07-21
YU42552B (en) 1988-10-31
US4322424A (en) 1982-03-30
SE453497B (sv) 1988-02-08
GB2068729B (en) 1983-10-19
GB2068729A (en) 1981-08-19
DE3102026A1 (de) 1982-03-04
FR2474493A1 (fr) 1981-07-31
FI810180L (fi) 1981-07-25
AT380474B (de) 1986-05-26
CH648023A5 (de) 1985-02-28
FI79840C (fi) 1990-03-12
FR2474493B1 (fr) 1985-12-13
IT1170638B (it) 1987-06-03
AU543758B2 (en) 1985-05-02
SE8100341L (sv) 1981-07-25
IE50884B1 (en) 1986-08-06
ATA32681A (de) 1985-10-15
FI79840B (fi) 1989-11-30
DE3102026C2 (el) 1990-05-31
IT8147604A0 (it) 1981-01-21
AU6651281A (en) 1981-07-30

Similar Documents

Publication Publication Date Title
EP0233106B1 (fr) (-)-Benzhydrylsulfinylacétamide, procédé de préparation et utilisation en thérapeutique
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
CH646412A5 (fr) Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits.
TW201039865A (en) Lyophilized preparations of proteasome inhibitors
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
FR2696740A1 (fr) Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
FR2650504A1 (fr) Hydrochlorure monohydrate de l'ester ethylique de l'acide 6-bromo-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carbonique, procede pour son obtention et medicament antiviral comprenant ce produit
JP6882538B2 (ja) 注射用組成物
LU83363A1 (fr) Compositions antitumeurs
CH670448A5 (el)
FR2505834A1 (fr) Derives de la thiazolidine
LU83081A1 (fr) Compositions antitumeurs
BE887220A (fr) Compositions antitumeurs
BE1001704A3 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
EP0449722B1 (fr) Nouveaux complexes de l'acide tiaprofénique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs dérivés
FR2662360A1 (fr) Composes d'inclusion de nimesulide avec la cyclodextrine, procedes pour la preparation de ces composes et compositions pharmaceutiques a activite analgesique et anti-inflammatoire les contenant.
LU82965A1 (fr) Nouveaux sels d'addition d'acides du 4'-(9-acridinylamino)methanesulf-m-anisidide,leur procede de production et composition pharmaceutique les contenant
EP3237015B1 (fr) Derives hydroxybisphosphoniques hydrosolubles de la doxorubicine
EP0209511A1 (fr) Chlorhydrates de chlorures de dérivés d'aminoalkyl-2 hydroxy-9 ellipticinium et compositions pharmaceutiques en contenant
FR2478092A1 (fr) Nouveaux sels de l'acide 5-fluoro-2-methyl-1-(p-(methyl-sulfinyl)-benzylidene)-indene-3-acetique, leur procede de preparation et leur application en therapeutique
JP2007106736A (ja) 注射用の医薬組成物
FR2491927A1 (fr) Derives de cephalexine solubles dans l'eau, et procede pour leur preparation
FR2507892A1 (fr) Compositions antibronchospastiques contenant un sel de theophylline avec un acide amine et leur preparation
CH665634A5 (en) Stable soluble catechin complexes - with a double salt of L-lysine, for liver protection and digestive ulcers
EP0070049A1 (fr) Dérivé de l'acide acétylsalicylique ayant activité analgésique, antipyrétique, antiphlogistique et bronchosécrétolytique